Clinical Trials
3 trialsNCT00877656 2024-03-18
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Emergent BioSolutions
Phase 2/3 Completed
NCT00071071 2023-05-18
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed
NCT00071084 2023-04-28
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed